Protagonist Therapeutics (PTGX) Shares Issued (2017 - 2025)
Historic Shares Issued for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to $5.7 million.
- Protagonist Therapeutics' Shares Issued fell 5304.12% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.5 million, marking a year-over-year increase of 939.37%. This contributed to the annual value of $26.5 million for FY2024, which is 7546.06% down from last year.
- Protagonist Therapeutics' Shares Issued amounted to $5.7 million in Q3 2025, which was down 5304.12% from $2.9 million recorded in Q2 2025.
- In the past 5 years, Protagonist Therapeutics' Shares Issued registered a high of $121.4 million during Q3 2021, and its lowest value of -$166000.0 during Q4 2021.
- For the 5-year period, Protagonist Therapeutics' Shares Issued averaged around $9.3 million, with its median value being $2.3 million (2023).
- Per our database at Business Quant, Protagonist Therapeutics' Shares Issued tumbled by 11143.7% in 2023 and then skyrocketed by 5028750.0% in 2024.
- Quarter analysis of 5 years shows Protagonist Therapeutics' Shares Issued stood at -$166000.0 in 2021, then surged by 433.13% to $553000.0 in 2022, then crashed by 98.55% to $8000.0 in 2023, then skyrocketed by 50287.5% to $4.0 million in 2024, then skyrocketed by 40.39% to $5.7 million in 2025.
- Its Shares Issued was $5.7 million in Q3 2025, compared to $2.9 million in Q2 2025 and $11.9 million in Q1 2025.